Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Mar 28 04:00PM ET
6.17
Dollar change
+0.30
Percentage change
5.11
%
Index- P/E- EPS (ttm)-3.56 Insider Own23.04% Shs Outstand6.00M Perf Week-3.59%
Market Cap37.02M Forward P/E- EPS next Y-1.00 Insider Trans0.00% Shs Float4.62M Perf Month-10.81%
Income-18.83M PEG- EPS next Q-0.59 Inst Own16.10% Short Float0.37% Perf Quarter14.05%
Sales16.03M P/S2.31 EPS this Y47.19% Inst Trans-11.62% Short Ratio1.13 Perf Half Y5.29%
Book/sh1.24 P/B4.98 EPS next Y44.35% ROA-90.88% Short Interest0.02M Perf Year21.70%
Cash/sh1.76 P/C3.50 EPS next 5Y- ROE-153.57% 52W Range3.83 - 8.08 Perf YTD3.66%
Dividend Est.- P/FCF- EPS past 5Y28.11% ROI-236.04% 52W High-23.64% Beta0.91
Dividend TTM- Quick Ratio1.49 Sales past 5Y77.42% Gross Margin82.51% 52W Low61.16% ATR (14)0.36
Dividend Ex-Date- Current Ratio1.76 EPS Y/Y TTM24.11% Oper. Margin-117.50% RSI (14)43.24 Volatility5.61% 5.60%
Employees68 Debt/Eq0.08 Sales Y/Y TTM86.57% Profit Margin-117.49% Recom1.00 Target Price23.10
Option/ShortNo / Yes LT Debt/Eq0.07 EPS Q/Q50.07% Payout- Rel Volume0.50 Prev Close5.87
Sales Surprise3.14% EPS Surprise-3.04% Sales Q/Q102.77% EarningsMar 13 AMC Avg Volume15.07K Price6.17
SMA20-5.38% SMA50-10.58% SMA2007.49% Trades Volume7,517 Change5.11%
Date Action Analyst Rating Change Price Target Change
Aug-14-20Upgrade BTIG Research Neutral → Buy $3.50
Nov-14-19Downgrade JMP Securities Mkt Outperform → Mkt Perform
Sep-26-19Resumed Cantor Fitzgerald Neutral $9
May-30-19Downgrade Cantor Fitzgerald Overweight → Neutral
May-15-19Downgrade BTIG Research Buy → Neutral
May-09-19Initiated Noble Capital Markets Outperform
Sep-21-18Initiated Cantor Fitzgerald Overweight
Mar-16-24 02:15PM
Mar-14-24 06:19AM
Mar-13-24 05:25PM
04:05PM
Mar-12-24 08:00AM
04:05PM Loading…
Mar-05-24 04:05PM
Feb-06-24 08:00AM
Jan-09-24 08:00AM
Dec-26-23 08:00AM
Dec-21-23 04:13PM
Dec-12-23 08:00AM
Nov-15-23 08:15AM
Nov-09-23 01:17PM
Nov-08-23 06:29PM
04:01PM
08:00AM Loading…
Nov-07-23 08:00AM
Oct-24-23 08:00AM
Oct-17-23 08:00AM
Oct-11-23 08:00AM
Oct-10-23 08:00AM
Oct-09-23 08:00AM
Oct-05-23 08:00AM
Sep-27-23 08:00AM
Sep-26-23 08:00AM
Sep-25-23 08:30AM
08:00AM
Sep-21-23 08:00AM
Sep-07-23 08:00AM
Aug-23-23 08:00AM
Aug-11-23 01:41PM
06:46AM Loading…
06:46AM
Aug-10-23 07:39AM
Aug-09-23 04:05PM
Aug-04-23 07:14AM
Aug-01-23 08:00AM
Jul-31-23 09:29AM
Jul-25-23 08:00AM
Jul-18-23 08:00AM
Jul-17-23 06:03AM
Jul-13-23 08:00AM
Jul-11-23 08:00AM
Jul-06-23 08:00AM
Jun-27-23 08:00AM
Jun-14-23 08:00AM
Jun-13-23 08:00AM
May-26-23 04:01PM
May-23-23 08:00AM
May-04-23 06:33AM
May-03-23 04:01PM
May-01-23 04:01PM
Apr-26-23 08:00AM
Apr-24-23 08:00AM
Apr-19-23 08:00AM
Apr-17-23 08:00AM
Apr-12-23 08:00AM
Apr-11-23 08:00AM
Apr-06-23 08:00AM
Apr-04-23 08:00AM
Mar-23-23 08:00AM
Mar-21-23 08:00AM
Mar-14-23 08:30AM
Mar-13-23 08:00AM
Mar-10-23 02:25AM
Mar-09-23 11:48AM
08:00AM
Mar-08-23 04:05PM
Mar-07-23 08:00AM
Mar-01-23 08:00AM
Feb-21-23 08:00AM
Feb-16-23 08:00AM
Feb-15-23 08:00AM
07:01AM
Feb-14-23 10:30AM
06:23AM
Feb-13-23 07:30AM
Feb-10-23 06:42AM
Feb-09-23 06:51AM
Feb-08-23 06:45AM
Feb-07-23 06:46AM
Feb-06-23 06:56AM
Feb-03-23 06:32AM
06:30AM
Feb-02-23 06:43AM
Feb-01-23 06:14AM
Jan-31-23 06:50AM
Jan-30-23 06:42AM
Jan-27-23 07:00AM
Jan-26-23 06:44AM
Jan-25-23 06:39AM
Jan-24-23 06:48AM
Jan-23-23 06:58AM
Jan-20-23 06:55AM
Jan-19-23 06:43AM
Jan-18-23 06:28AM
Jan-17-23 08:00AM
06:27AM
Jan-13-23 06:56AM
Jan-12-23 06:50AM
Jan-11-23 06:53AM
Jan-09-23 06:31AM
electroCore, Inc. engages in the provision of non-invasive vagus nerve stimulation (nVNS) therapy. It develops a platform bioelectronic medical therapy that modulates neurotransmitters and immune function through its effects on both the peripheral and central nervous systems. The company was founded by Joseph P. Errico, Steven M. Mendez, Peter S. Staats and Thomas J. Errico in September 2005 and is headquartered in Rockaway, NJ.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Goldberger Daniel SChief Executive OfficerSep 15 '23Buy5.551,5008,332136,060Sep 19 08:30 AM
Goldberger Daniel SChief Executive OfficerAug 02 '23Buy4.3550,991221,81184,560Aug 03 03:31 PM